Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan…
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes…
Brickell Biotech Inc (NASDAQ: BBI) Announces Dosing of First Subject with…
Cronos Group Inc (NASDAQ: CRON) and Ginkgo Bioworks Holdings Inc (NYSE:…
Finance
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:SAVA
Tag: NASDAQ:SAVA
Cassava Sciences Inc. (NASDAQ: SAVA) Launches New Clinical Website Offering Information...
Gavins Felicity
-
January 3, 2022
0
Journal of Neuroscience Didn’t Find Data Manipulation Evidence in Research Article...
Matt Wade
-
November 17, 2021
0
Annovis Bio Inc (NYSEAMERICAN: ANVS), Cassava Sciences Inc (NASDAQ: SAVA), Honest...
Kate Hudson
-
October 11, 2021
0
Cassava Sciences Inc. (NASDAQ: SAVA) Releases Clinical Data On Simufilam In...
Matt Wade
-
September 28, 2021
0
Cassava Sciences Inc. (NASDAQ:SAVA) Released Addition Phase 2b Clinical Study Results...
Ward Sport
-
November 10, 2020
0
CTAD 2020 Picks Cassava Sciences Inc.’s (NASDAQ:SAVA) Phase 2b Sumifilam Study...
Matt Wade
-
October 14, 2020
0
Cassava Sciences Inc. (NASDAQ:SAVA) Demonstrates Directional Improvement In Alzheimer’s Patients Treated...
Matt Wade
-
September 17, 2020
0
The USAN Announces a Commercial Brand Name for PTI-125; Lead Drug...
Kate Hudson
-
September 1, 2020
0
Cassava Sciences Inc (NASDAQ:SAVA) Expects To Release Clinical Results Of Phase...
Kate Hudson
-
August 26, 2020
0
Recent Post
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Kate Hudson
-
July 4, 2022
0
Chimerix Inc (NASDAQ: CMRX) has received a $25.3 million contract agreement from the Public Health Agency of Canada for the procurement of TEMBEX (brincidofovir)....
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...
July 1, 2022
Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...
June 30, 2022
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...
June 30, 2022
Why Your Body Needs Nitric Oxide Boost Beets For More Energy...
June 28, 2022